CM
APYX icon

Caption Management’s Apyx Medical APYX Stock Holding History

Caption Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$685K Buy
185,751
+25,344
+16% +$94.7K ﹤0.01% 1121
2025
Q4 		$561K Buy
160,407
+36,475
+29% +$127K ﹤0.01% 1220
2025
Q3 		$265K Buy
123,932
+16,224
+15% +$34.3K ﹤0.01% 1428
2025
Q2 		$242K Sell
107,708
-239
-0.2% -$337 ﹤0.01% 1234
2025
Q1 		$148K Sell
107,947
-5,640
-5% -$7.77K ﹤0.01% 1317
2024
Q4 		$179K Sell
113,587
-1,963
-2% -$2.75K ﹤0.01% 1295
2024
Q3 		$143K Hold
115,550
– – ﹤0.01% 1096
2024
Q2 		$155K Sell
115,550
-558
-0.5% -$823 ﹤0.01% 986
2024
Q1 		$158K Buy
116,108
+84,777
+271% +$180K ﹤0.01% 1025
2023
Q4 		$82.1K Buy
31,331
+7,375
+31% +$17.9K ﹤0.01% 1195
2023
Q3 		$76.7K Buy
+23,956
New +$112K ﹤0.01% 1172
2019
Q2 		– Sell
-10,000
Closed -$63K – 647
2019
Q1 		$63K Buy
+10,000
New +$77.4K ﹤0.01% 532

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Caption Management's APYX Position: Q1 2026 in Review

Caption Management increased its Apyx Medical (APYX) stake by 16% in Q1 2026, buying an estimated $94.7K and bringing the position to 185,751 shares worth $685K. The position accounts for ﹤0.01% of the portfolio, ranked #1121.

Caption Management first reported a position in APYX in Q1 2019 and has held it in 12 quarters since. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Caption Management held 185,751 shares of Apyx Medical worth $685K as of Q1 2026.
  • Caption Management bought 25,344 Apyx Medical shares in Q1 2026, an estimated $94.7K.
  • Apyx Medical made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1121 holding.
  • Caption Management first reported a position in Apyx Medical in Q1 2019 and has held it in 12 quarters since.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.